Almac Pharma Services Announces Two Vice President Appointments

January 23, 2023

Craigavon, Northern Ireland – 23 January 2023 – Almac Pharma Services, a member of the Almac

Group providing innovative pharmaceutical development, manufacture and commercial services, has announced the appointment of two new Vice Presidents. Both will serve on the Almac Pharma Services’ Executive Leadership Team, reporting directly to John McQuaid, President & Managing Director of Almac Pharma Services.

Trevor Clarke has been appointed to the position of Vice President, Analytical Operations, Pharma Services.

Harry Lindenmuth has been appointed to the position of Vice President, Operations Audubon, Pharma Services.

John said: “It gives me great pleasure to announce these two appointments.

“Trevor has been a key member of the team since he joined as a Quality Manager in 2005.  He has held various site and global quality leadership roles and has been influential in supporting growth and service expansion of the business. This appointment to the Almac Pharma Services’ Executive team underlines the importance placed on Analytical Operations which underpins so many of the services we deliver to our clients.”

“Harry joined Almac as Audubon Site Director in June 2020.  He has been influential in the strong performance of the Pennsylvanian based site with delivery metrics resulting in positive client sentiment and leaving the site well poised for further growth.”

“I look forward to their contribution to our continued success.”


About Almac Pharma Services

Tailormade pharmaceutical development and commercial solutions

With over 50 years’ experience, Almac Pharma Services is a world leading outsourcing partner to the global pharmaceutical and biotechnology industry. 

With facilities located in Europe and the US, we provide tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution.

About Almac Group

A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Its innovative services range from R&D, biomarker discovery development and commercialization, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization which has grown organically over the past five decades now employing over 6,600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

To keep up to date with latest news, follow us on Twitter and LinkedIn or visit


Back to news